This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd, Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ge Pan: Innovator in Breast Cancer Treatment
Introduction
Ge Pan is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of breast cancer. His innovative approach has the potential to change the landscape of cancer treatment.
Latest Patents
Ge Pan holds a patent for the use of a mitoxantrone preparation in the preparation of a drug for diagnosing and treating breast cancer. This patent outlines the use of mitoxantrone and/or a pharmaceutically acceptable salt in the preparation of a lymphatic tracer for diseases associated with breast resection. The preparation has shown no local or systemic toxic and side effects after local injection, indicating good tolerance, effectiveness, and safety. This innovation provides a new treatment idea for thoroughly curing breast cancer in patients.
Career Highlights
Throughout his career, Ge Pan has worked with prominent companies in the pharmaceutical industry. He has been associated with Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd and Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in medical treatments and drug development.
Collaborations
Ge Pan has collaborated with notable professionals in his field, including Xun Li and Quanhua Huang. These collaborations have further enhanced his research and development efforts in cancer treatment.
Conclusion
Ge Pan's innovative work in the field of breast cancer treatment exemplifies the impact of dedicated inventors in medical science. His contributions are paving the way for new therapeutic options for patients battling breast cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile